Volume 28, Number 11—November 2022
Research
Differences in SARS-CoV-2 Clinical Manifestations and Disease Severity in Children and Adolescents by Infecting Variant
Figure 2

Figure 2. Flow diagram of sample and patient selection for SARS CoV-2 variant screening of nasopharyngeal samples at Nationwide Children’s Hospital, Columbus, Ohio, USA, during January 1, 2021–January 15, 2022. After excluding patients >22 years of age and duplicate entries, 676 patients with positive SARS-CoV-2 tests during January 1–September 19, 2021, and December 15, 2021–January 15, 2022 were included in the clinical analyses. Other variants were Beta, Iota, Zeta, Eta, Epsilon, Gamma, Mu, and other variants under investigation.
1These authors contributed equally to and co-directed this work.
Page created: October 06, 2022
Page updated: October 21, 2022
Page reviewed: October 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.